Scholarlink

Background <p>This study aimed to identify potentially pathogenic variants in the <i>KIF11</i> gene in patients with Familial Exudative Vitreoretinopathy (FEVR) and to evaluate their impact on <i>KIF11</i> function and associated cellular mechanisms.</p> Methods <p>Three unrelated families diagnosed with FEVR were analyzed through Sanger sequencing and gene panel testing to identify genetic variants. Transfected HEK293T cells were used to assess the effects of identified variants on KIF11 protein expression. Human retinal endothelial cells (HRECs) were utilized to model KIF11 dysfunction via lentiviral knockdown, along with the introduction of the identified variants.</p> Results <p>Three <i>KIF11</i> variants—p.Arg138His, p.Arg312Ter, and p.Ser348fsTer8—were identified in FEVR patients. Arg312Ter and Ser348fsTer8 caused KIF11 truncation. <i>KIF11</i> knockdown and Arg138His expression in HRECs impaired proliferation. Arg138His disrupted KIF11-mLST8 interaction, leading to mTORC1 hyperactivation (increased p70S6K/4EBP1 phosphorylation) and ROS generation, activating p53/p21. mTORC1 inhibition partially rescued these effects. Additionally, <i>KIF11</i> variants independently compromised HRECs cell cycle progression.</p> Conclusions <p><i>KIF11</i> variants, particularly Arg138His, diminish protein function through distinct mechanisms involving mTORC1 hyperactivation and cell cycle dysregulation, contributing to FEVR pathogenesis. These findings highlight the need for combinatorial therapeutic strategies to address <i>KIF11</i>-related disorders.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

KIF11 variants in familial exudative vitreoretinopathy leading to mTORC1 overactivation and impaired cell cycle progression

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年11月19日

查看全文
  • Min Liu,
  • Shengliu Pan,
  • Erkuan Dai,
  • Rulian Zhao

摘要

Background

This study aimed to identify potentially pathogenic variants in the KIF11 gene in patients with Familial Exudative Vitreoretinopathy (FEVR) and to evaluate their impact on KIF11 function and associated cellular mechanisms.

Methods

Three unrelated families diagnosed with FEVR were analyzed through Sanger sequencing and gene panel testing to identify genetic variants. Transfected HEK293T cells were used to assess the effects of identified variants on KIF11 protein expression. Human retinal endothelial cells (HRECs) were utilized to model KIF11 dysfunction via lentiviral knockdown, along with the introduction of the identified variants.

Results

Three KIF11 variants—p.Arg138His, p.Arg312Ter, and p.Ser348fsTer8—were identified in FEVR patients. Arg312Ter and Ser348fsTer8 caused KIF11 truncation. KIF11 knockdown and Arg138His expression in HRECs impaired proliferation. Arg138His disrupted KIF11-mLST8 interaction, leading to mTORC1 hyperactivation (increased p70S6K/4EBP1 phosphorylation) and ROS generation, activating p53/p21. mTORC1 inhibition partially rescued these effects. Additionally, KIF11 variants independently compromised HRECs cell cycle progression.

Conclusions

KIF11 variants, particularly Arg138His, diminish protein function through distinct mechanisms involving mTORC1 hyperactivation and cell cycle dysregulation, contributing to FEVR pathogenesis. These findings highlight the need for combinatorial therapeutic strategies to address KIF11-related disorders.